HOTH
Hoth Therapeutics Inc
NASDAQ · Pharmaceuticals
$0.81
+0.04 (+4.95%)
Open$0.78
Previous Close$0.77
Day High$0.82
Day Low$0.78
52W High$3.20
52W Low$1.17
Volume—
Avg Volume650.0K
Market Cap12.54M
P/E Ratio14.39
EPS$0.16
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+221.7% upside
Current
$0.81
$0.81
Target
$2.60
$2.60
$1.73
$2.60 avg
$4.05
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.55M | 4.47M | 5.09M |
| Net Income | 883.9K | 919.3K | 807.7K |
| Profit Margin | 19.4% | 20.6% | 15.9% |
| EBITDA | 1.12M | 1.15M | 1.14M |
| Free Cash Flow | 1.08M | 1.03M | 790.7K |
| Rev Growth | +13.3% | +17.8% | +20.0% |
| Debt/Equity | 0.67 | 0.60 | 0.55 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |